Pursuant to the Code of Insider Trading of the Company, Zydus Lifesciences has informed that the trading window shall remain closed from April 1, 2023 till 48 hours after the declaration of audited financial results for the quarter / financial year ending on March 31, 2023 for the Directors and Designated Persons and their immediate relatives, for trading in the equity shares of the Company. The date of board meeting for approving the audited financial results for the quarter / financial year ending on March 31, 2023 will be intimated in due course of time.
The above information is a part of company’s filings submitted to BSE.
| Company Name | CMP |
|---|---|
| Sun Pharma Inds. | 1672.10 |
| Dr. Reddys Lab | 1238.50 |
| Cipla | 1237.90 |
| Zydus Lifesciences | 942.00 |
| Lupin | 2334.30 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: